drug
Abrysvo
Marketedupdated 3mo agoby $PFE PFIZER INC
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying Abrysvo
- —Evaluating the Benefits of RSV Maternal Vaccination Using a Scottish National Dataset
- —A Study to Learn About ABRYSVO Vaccine in Older Adults to Prevent Severe Respiratory Syncytial Virus (RSV) Disease
- phase1Safety, Tolerability and Immunogenicity of a Maternal Respiratory Syncytial Virus (RSV) Vaccine (MKK900) in Healthy Adult Women
- —Effectiveness of ABRYSVO® Maternal Respiratory Syncytial Virus (RSV) Vaccine Against RSV in Infants in Western Pennsylvania
- —Evaluating ABRYSVO Maternal Vaccine Effectiveness Among Infants
- —STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON)
- —Impact and Effectiveness of ABRYSVO® Vaccination During Pregnancy
News(1)
- OB-GYN association, deviating from CDC guidance, issues its own vaccine recommendationsThe American College of Obstetricians and Gynecologists has released a recommended vaccine schedule during pregnancy, one that diverges from CDC guidance.stat · 2mo ago
Data sources
last refreshed 15m ago
Found something off?
comments(0)
5-min edit window · permanent after that